Breaking News
-
Dec 06 2021FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns
the U.S. Food and Drug Administration revised the emergency use…
Read more -
Nov 14 2021Network 7 Media Group’s India Leadership Conclave 2021 to debate Reforms, Honour shining stars of Indian Inc.
Top Industry Experts, Social Reformers, Policy Makers Will Congregate To…
Read more -
Sep 09 2021Strengthening health emergency security systems top priority: WHO
The World Health Organization and Member countries of South-East Asia…
Read more -
Aug 29 2021Union Minister of Health and Family Welfare, GoI, launches first commercial batch of COVAXIN® manufactured in Ankleshwar, Gujarat
With specialised bio safety containment facilities in Hyderabad, Malur, Ankleshwar,…
Read more -
Aug 20 2021Pharma Leaders 2021 to debate Healthcare Reforms, Honour top Healthcare Leaders at 14th Annual Pharma Leaders Power Brand Awards 2021
Pharma Leaders, Nation’s most prestigious & credible healthcare media will…
Read more -
Aug 13 2021Health Minister Mansukh Mandaviya urges pharma industry to increase share of generic drugs in India
Union Health Minister Mansukh Mandaviya on Thursday urged the pharma…
Read more -
Jul 17 2021Ipsen and IRLAB ink pact to develop & commercialise newl dopamine D3-receptor antagonist, mesdopetam to treat Parkinson’s disease
Ipsen and IRLAB announced the signing of a licensing agreement,…
Read more -
Jul 17 2021US FDA’s CRDA committee votes against approval of AstraZeneca’s roxadustat to treat anaemia in chronic kidney disease
AstraZeneca announced that the Food and Drug Administration’s (FDA) Cardiovascular…
Read more -
Jul 17 2021EMA accepts Hutchmed’s MAA for surufatinib to treat pancreatic and extra-pancreatic neuroendocrine tumors
Hutchmed announced that the European Medicines Agency (EMA) has validated…
Read more -
Jul 17 2021Vir Biotechnology begins patient dosing in phase 2 MARCH study of combination of VIR-2218 & VIR-3434 as functional cure regimen for chronic HBV infection
Vir Biotechnology announced that the first patient has been dosed…
Read more
